Oddity Tech Ltd. operates as a consumer tech company that builds digital-first brands for the beauty and wellness industries in the United States and internationally. It serves consumers through its AI-driven online platform, which uses data science, machine learning, and computer vision capabilities to identify consumer needs, and develop solutions in the form of beauty, wellness, and technology products. The company provides a portfolio of products, including face and complexion, eye, brow and lip products, makeup tools, skincare, haircare, and supplements under the IL MAKIAGE and SpoiledChild brands. In addition, it operates ODDITY LABS, a biotechnology center, which deploys AI-based molecule discovery technology to identify and launch novel ingredients that delivers performance and outcomes for consumers in beauty and wellness. Oddity Tech Ltd. was incorporated in 2013 and is headquartered in Tel Aviv, Israel.

ODDITY Tech Ltd.

Odd Burger Corporation ( ($TSE:ODD) ) has issued an announcement. Odd Burger Corporation has warned that it will miss the January 28, 2026 deadline...

Odd Burger Delays Annual Filings After Financing Default Triggers Liquidity Crunch

Bernstein analyst Lee Hambright maintained a Buy rating on Insulet today and set a price target of $380.00. Hambright covers the Healthcare sector,...

Insulet (PODD) Receives a Buy from Bernstein

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Insulet today and set a price target of $360.00. According to TipRanks, Biegelsen is...

Wells Fargo Sticks to Their Buy Rating for Insulet (PODD)

The latest update is out from ODDITY Tech Ltd. Class A ( ($ODD) ). On January 12, 2026, ODDITY Tech Ltd. disclosed that it has amended its existing...

ODDITY Tech Secures Expanded $350 Million Credit Facilities to Fund Growth

In a report released on January 7, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Insulet, with a price target of $380.00. The com...

RBC Capital Sticks to Their Buy Rating for Insulet (PODD)

The latest announcement is out from ODDITY Tech Ltd. Class A ( ($ODD) ). On January 7, 2026, ODDITY Tech Ltd. reported that Dr. Ido Bachelet, forme...

ODDITY Tech Announces Leadership Change at ODDITY LABS, Affirms Outlook

Modular Medical ( ($MODD) ) just unveiled an announcement. On June 30, 2025, Modular Medical disclosed that its shares had traded below Nasdaq’s $1...

Modular Medical Granted Nasdaq Extension to Regain Compliance

Insulet ($PODD) announced an update on their ongoing clinical study. Study Overview: Insulet Corporation is running a new clinical study titled “An...

Insulet’s New Omnipod M Study Targets the Untapped Type 2 Diabetes Pump Market

Insulet ($PODD) announced an update on their ongoing clinical study. Study Overview Insulet’s new study, officially titled “Safety and Efficacy of ...

Insulet’s Omnipod SmartAdjust 2.0 Trial Wraps Up: What Investors Should Watch Next

In a report released on December 16, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Insulet, with a price target of $380.00. The c...

RBC Capital Sticks to Its Buy Rating for Insulet (PODD)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Insulet (PODD – Research Report) and Novan (NOVN – R...

Current Yield	N/A	Payout Ratio	N/A
Annual DPS	$0.00	Growth Streak	0 years
Ex-Dividend	Invalid Date	Pay Date	Invalid Date
Frequency	NA	Quarterly Est	$0.00

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ODD	$35.34	+4.56%	945.61K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ODD	$35.34	+4.6%	945.61K
3
4
5
6

ODD

ODD

Dividend Overview

Get ODDITY Tech Ltd. Data in Excel

Get ODDITY Tech Ltd. Data in Excel